Literature DB >> 12136087

Alternate exon insertion controls selective ubiquitination and degradation of different AUF1 protein isoforms.

Gaurav Laroia1, Robert J Schneider.   

Abstract

The A+U-rich element (ARE) in the 3' non-coding region (3' NCR) of short-lived cytokine mRNAs binds several regulatory proteins, including hnRNP D/AUF1, which comprises four isoforms of 37, 40, 42 and 45 kDa. ARE-mRNA degradation involves ubiquitin-proteasome activity, and one or more AUF1 proteins are thought to be ubiquitinated. Here we have characterized the mechanism for differential ubiquitination and degradation of the different AUF1 protein isoforms. We demonstrate in an in vitro ubiquitination system that the p37, followed by the p40 protein, are strongly ubiquitinated, whereas the p42 and p45 forms are not. Over expression in cells of enzymes that control the ubiquitin cycle were found to control p37 and p40 AUF1 protein levels through ubiquitination and proteasome activity, but not p42 and p45 forms. The p42 and p45 AUF1 proteins share a C-terminal exon 7 that is not found in the p37/p40 isoforms. Our studies show that exon 7 blocks ubiquitination and rapid degradation of AUF1 proteins, whereas its deletion permits ubiquitination to occur and promotes rapid turnover of AUF1 proteins. Thus, the stabilities of AUF1 isoforms are differentially controlled by insertion of an alternate exon that regulates ubiquitin targeting activity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12136087      PMCID: PMC135764          DOI: 10.1093/nar/gkf444

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  59 in total

1.  AU binding proteins recruit the exosome to degrade ARE-containing mRNAs.

Authors:  C Y Chen; R Gherzi; S E Ong; E L Chan; R Raijmakers; G J Pruijn; G Stoecklin; C Moroni; M Mann; M Karin
Journal:  Cell       Date:  2001-11-16       Impact factor: 41.582

2.  Unp, a mouse gene related to the tre oncogene.

Authors:  K Gupta; N G Copeland; D J Gilbert; N A Jenkins; D A Gray
Journal:  Oncogene       Date:  1993-08       Impact factor: 9.867

3.  Unraveling a cytoplasmic role for hnRNP D in the in vivo mRNA destabilization directed by the AU-rich element.

Authors:  P Loflin; C Y Chen; A B Shyu
Journal:  Genes Dev       Date:  1999-07-15       Impact factor: 11.361

4.  Functional heterogeneity of ubiquitin carrier proteins.

Authors:  C M Pickart; I A Rose
Journal:  J Biol Chem       Date:  1985-02-10       Impact factor: 5.157

5.  Adenovirus inhibition of cellular protein synthesis involves inactivation of cap-binding protein.

Authors:  J T Huang; R J Schneider
Journal:  Cell       Date:  1991-04-19       Impact factor: 41.582

6.  Nuclear proteins that bind the pre-mRNA 3' splice site sequence r(UUAG/G) and the human telomeric DNA sequence d(TTAGGG)n.

Authors:  F Ishikawa; M J Matunis; G Dreyfuss; T R Cech
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

7.  An A + U-rich element RNA-binding factor regulates c-myc mRNA stability in vitro.

Authors:  G Brewer
Journal:  Mol Cell Biol       Date:  1991-05       Impact factor: 4.272

8.  A ubiquitin C-terminal isopeptidase that acts on polyubiquitin chains. Role in protein degradation.

Authors:  T Hadari; J V Warms; I A Rose; A Hershko
Journal:  J Biol Chem       Date:  1992-01-15       Impact factor: 5.157

9.  Ubiquitin-activating enzyme. Mechanism and role in protein-ubiquitin conjugation.

Authors:  A L Haas; J V Warms; A Hershko; I A Rose
Journal:  J Biol Chem       Date:  1982-03-10       Impact factor: 5.157

10.  Components of ubiquitin-protein ligase system. Resolution, affinity purification, and role in protein breakdown.

Authors:  A Hershko; H Heller; S Elias; A Ciechanover
Journal:  J Biol Chem       Date:  1983-07-10       Impact factor: 5.157

View more
  25 in total

1.  Roles of AUF1 isoforms, HuR and BRF1 in ARE-dependent mRNA turnover studied by RNA interference.

Authors:  Ines Raineri; Daniel Wegmueller; Brigitte Gross; Ulrich Certa; Christoph Moroni
Journal:  Nucleic Acids Res       Date:  2004-02-19       Impact factor: 16.971

2.  AUF-1 and YB-1 are critical determinants of β-globin mRNA expression in erythroid cells.

Authors:  Sebastiaan van Zalen; Grace R Jeschke; Elizabeth O Hexner; J Eric Russell
Journal:  Blood       Date:  2011-12-01       Impact factor: 22.113

Review 3.  The role of AUF1 in regulated mRNA decay.

Authors:  Frances M Gratacós; Gary Brewer
Journal:  Wiley Interdiscip Rev RNA       Date:  2010 Nov-Dec       Impact factor: 9.957

Review 4.  The Regulation of Synaptic Protein Turnover.

Authors:  Beatriz Alvarez-Castelao; Erin M Schuman
Journal:  J Biol Chem       Date:  2015-10-09       Impact factor: 5.157

5.  Selective degradation of AU-rich mRNAs promoted by the p37 AUF1 protein isoform.

Authors:  Bedabrata Sarkar; Qiaoran Xi; Cheng He; Robert J Schneider
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

6.  Involvement of the RNA-binding protein ARE/poly(U)-binding factor 1 (AUF1) in the cytotoxic effects of proinflammatory cytokines on pancreatic beta cells.

Authors:  E Roggli; S Gattesco; A Pautz; R Regazzi
Journal:  Diabetologia       Date:  2011-12-13       Impact factor: 10.122

7.  AUF1 cell cycle variations define genomic DNA methylation by regulation of DNMT1 mRNA stability.

Authors:  Jerome Torrisani; Alexander Unterberger; Sachin R Tendulkar; Keisuke Shikimi; Moshe Szyf
Journal:  Mol Cell Biol       Date:  2006-10-09       Impact factor: 4.272

8.  Tumor necrosis factor activates a conserved innate antiviral response to hepatitis B virus that destabilizes nucleocapsids and reduces nuclear viral DNA.

Authors:  Robyn Puro; Robert J Schneider
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

Review 9.  Post-transcriptional control of gene expression by AUF1: mechanisms, physiological targets, and regulation.

Authors:  Elizabeth J F White; Gary Brewer; Gerald M Wilson
Journal:  Biochim Biophys Acta       Date:  2012-12-14

10.  Proteasome inhibitor PS-341 (VELCADE) induces stabilization of the TRAIL receptor DR5 mRNA through the 3'-untranslated region.

Authors:  Karthikeyan Kandasamy; Andrew S Kraft
Journal:  Mol Cancer Ther       Date:  2008-05       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.